MacLean Carroll Sellars, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cancer Vaccines | 1 | 2022 | 1042 | 0.470 |
Why?
|
Vaccines | 1 | 2022 | 842 | 0.440 |
Why?
|
Heart Murmurs | 1 | 2020 | 92 | 0.170 |
Why?
|
Sarcoma, Myeloid | 1 | 2020 | 52 | 0.170 |
Why?
|
Teaching Rounds | 1 | 2022 | 282 | 0.150 |
Why?
|
Immune System | 1 | 2022 | 801 | 0.140 |
Why?
|
Neoplasms | 2 | 2022 | 22385 | 0.130 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2020 | 335 | 0.130 |
Why?
|
Heart Neoplasms | 1 | 2020 | 374 | 0.130 |
Why?
|
Thymus Gland | 3 | 2006 | 1266 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2909 | 0.090 |
Why?
|
Immunity, Innate | 1 | 2022 | 3078 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3431 | 0.080 |
Why?
|
Glioblastoma | 1 | 2025 | 3526 | 0.080 |
Why?
|
Receptors, Steroid | 2 | 2006 | 156 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 2 | 2006 | 1813 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4907 | 0.060 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 861 | 0.060 |
Why?
|
Response Elements | 1 | 2006 | 308 | 0.060 |
Why?
|
Ikaros Transcription Factor | 1 | 2006 | 233 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3620 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2006 | 303 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2025 | 9198 | 0.050 |
Why?
|
Clonal Deletion | 1 | 2003 | 75 | 0.050 |
Why?
|
Receptor, Notch1 | 1 | 2006 | 520 | 0.050 |
Why?
|
Cell Lineage | 1 | 2012 | 2574 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2012 | 2568 | 0.050 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2006 | 1141 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2012 | 3827 | 0.040 |
Why?
|
Mice | 4 | 2022 | 82017 | 0.040 |
Why?
|
Morbidity | 1 | 2022 | 1758 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2006 | 2429 | 0.030 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 2 | 2006 | 66 | 0.030 |
Why?
|
Paclitaxel | 1 | 2022 | 1736 | 0.030 |
Why?
|
Animals | 5 | 2022 | 169337 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2012 | 10267 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2022 | 3553 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2006 | 9614 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2006 | 11668 | 0.020 |
Why?
|
Transcription Factors | 2 | 2006 | 12166 | 0.020 |
Why?
|
Humans | 6 | 2025 | 768393 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3858 | 0.020 |
Why?
|
Intracellular Fluid | 1 | 2006 | 201 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 7075 | 0.010 |
Why?
|
Female | 5 | 2025 | 397089 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11854 | 0.010 |
Why?
|
Aged | 2 | 2025 | 171562 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 1493 | 0.010 |
Why?
|
Middle Aged | 2 | 2025 | 223491 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2006 | 2460 | 0.010 |
Why?
|
Up-Regulation | 1 | 2006 | 4142 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2025 | 36849 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2006 | 22355 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8326 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 5801 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13423 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 6234 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17626 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2003 | 5900 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2003 | 5496 | 0.010 |
Why?
|
Apoptosis | 1 | 2006 | 9516 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2003 | 9562 | 0.010 |
Why?
|
Adult | 1 | 2025 | 223640 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2006 | 10478 | 0.010 |
Why?
|
Male | 1 | 2025 | 364902 | 0.000 |
Why?
|
Signal Transduction | 1 | 2006 | 23631 | 0.000 |
Why?
|
Mutation | 1 | 2006 | 30228 | 0.000 |
Why?
|